FATE THERAPEUTICS INC's ticker is FATE and the CUSIP is 31189P102. A total of 253 filers reported holding FATE THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.84 and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $9,161,014 | -68.3% | 907,930 | -29.6% | 0.01% | -70.8% |
| Q3 2022 | $28,883,000 | -8.3% | 1,288,858 | +1.4% | 0.02% | 0.0% |
| Q2 2022 | $31,485,000 | -35.7% | 1,270,565 | +0.6% | 0.02% | -27.3% |
| Q1 2022 | $48,961,000 | -32.7% | 1,262,866 | +1.6% | 0.03% | -25.0% |
| Q4 2021 | $72,719,000 | -1.6% | 1,242,843 | -0.3% | 0.04% | -4.3% |
| Q3 2021 | $73,884,000 | -17.5% | 1,246,570 | +20.8% | 0.05% | -13.2% |
| Q2 2021 | $89,574,000 | +93.4% | 1,032,080 | +83.8% | 0.05% | +82.8% |
| Q1 2021 | $46,304,000 | -5.3% | 561,595 | +4.5% | 0.03% | -9.4% |
| Q4 2020 | $48,890,000 | +153.5% | 537,664 | +11.5% | 0.03% | +146.2% |
| Q3 2020 | $19,283,000 | +5.6% | 482,426 | -9.4% | 0.01% | 0.0% |
| Q2 2020 | $18,260,000 | -11.2% | 532,204 | -42.5% | 0.01% | -27.8% |
| Q1 2020 | $20,567,000 | +28.2% | 926,009 | +13.0% | 0.02% | +38.5% |
| Q4 2019 | $16,044,000 | +22.9% | 819,810 | -2.5% | 0.01% | +18.2% |
| Q3 2019 | $13,052,000 | +26.4% | 840,430 | +65.2% | 0.01% | +22.2% |
| Q2 2019 | $10,329,000 | – | 508,841 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Polaris Venture Management Co. V, L.L.C. | 569,889 | $51,820,000 | 67.63% |
| Johnson & Johnson Innovation - JJDC, Inc. | 3,379,064 | $307,258,000 | 39.62% |
| Darwin Global Management, Ltd. | 952,847 | $86,642,000 | 24.18% |
| Redmile Group, LLC | 12,629,737 | $1,148,422,000 | 13.91% |
| DAFNA Capital Management LLC | 334,360 | $30,403,000 | 9.05% |
| Casdin Capital, LLC | 3,050,000 | $277,337,000 | 8.22% |
| Grosvenor Holdings, L.L.C. | 1,459,517 | $132,714,000 | 7.23% |
| Copernicus Capital Management, LLC | 3,240 | $295,000 | 4.60% |
| Eversept Partners, LP | 399,499 | $36,326,444 | 4.26% |
| Ally Bridge Group (NY) LLC | 260,000 | $23,642,000 | 4.05% |